Experimental Lung Research

Experimental Lung Research is a peer-reviewed journal for the cell and molecular biology of the lung, published by Taylor & Francis for laboratory and clinical investigators.《实验肺研究》是一份同行评议期刊，专攻肺的细胞与分子生物学，由 Taylor & Francis 出版，服务对象为实验室研究者与临床医生。

Its 2025 Journal Impact Factor stands at 1.9 against a five-year figure of 1.5, and the title ranks 73rd of 107 in the respiratory system category.2025 年该刊的影响因子为 1.9，五年影响因子为 1.5，在呼吸系统类目 107 种期刊中排第 73 位。

Scope

• Papers concentrate on the cell and molecular biology of the lung, from receptor signalling in airway smooth muscle to transcriptional control of alveolar repair.稿件集中在肺的细胞与分子生物学，从气道平滑肌的受体信号到肺泡修复的转录调控都有涉及。
• Lung development and ageing form a second axis, with work on branching morphogenesis, alveolarization and the slow loss of elastic recoil that marks the ageing lung.肺发育与衰老是第二条主线，分支形态发生、肺泡化与弹性回缩力缓慢丧失都在讨论之列。
• Airway and alveolar epithelium attract steady interest, especially barrier integrity, ciliary function, mucus secretion and the repair response that follows injury.气道与肺泡上皮始终受关注，屏障完整性、纤毛功能与黏液分泌，以及损伤后的修复反应都是常见题材。
• Fibrosis and tissue remodelling appear often, including myofibroblast activation, matrix turnover and the signalling loops that keep a scar in place.纤维化与组织重塑出现频繁，肌成纤维细胞活化、基质周转与维持瘢痕的信号环路都属常见主题。
• Inflammation and pulmonary immunity are handled as mechanistic problems, with cytokine networks and macrophage polarisation tested in intact lung tissue rather than in cell lines alone.炎症与肺免疫按机制问题处理，细胞因子网络与巨噬细胞极化要在完整肺组织中检验，单用细胞系不够。
• Surfactant biology and pulmonary lipid metabolism receive regular coverage, from lamellar body assembly to the biophysical behaviour of surfactant films at the alveolar interface.表面活性物质与肺脂质代谢定期见刊，内容从板层小体组装延伸到肺泡界面上表面活性膜的生物物理行为。
• Acute lung injury and repair are welcomed, particularly studies that separate reversible epithelial damage from the pathways locking tissue into a fibrotic endpoint.急性肺损伤与修复研究同样受欢迎，尤其看重能把可逆性上皮损伤与导致纤维化终点的通路分开的工作。
• Stem cells and organoids have gained ground, with lung organoids, precision-cut slices and co-culture systems used to test regenerative claims outside the whole animal.干细胞与类器官方向近年升温，肺类器官、精切肺片与共培养体系被用来在整体动物之外检验再生假说。
• Imaging and physiological measurement qualify when they quantify structure or function, as with micro-computed tomography, forced oscillation and intravital microscopy of the pulmonary microcirculation.影像与生理测量类论文须给出结构或功能的定量结果，微型计算机断层扫描、振荡肺功能与肺微循环活体显微观察都算合格手段。
• Environmental and occupational exposure stays central, covering tobacco smoke, particulate matter, ozone, engineered nanomaterials and the pulmonary toxicity each of them provokes.环境与职业暴露是核心议题，烟草烟雾、颗粒物、臭氧以及工程纳米材料造成的肺毒性都在其中。
• Lung tumour biology is read through the same experimental lens, with papers on the tumour microenvironment, epithelial-mesenchymal transition and acquired drug resistance in preclinical models.肺肿瘤生物学沿用同一实验视角，肿瘤微环境、上皮间质转化与临床前模型中的获得性耐药都是选题。
• Animal models and in vitro systems sit at the centre of what the title publishes, and authors must justify species choice, exposure route and the physiological relevance of the preparation.动物模型与体外体系处于收稿范围中心，作者需说明物种选择、暴露途径以及制备方式的生理相关性。
• Respiratory tract anatomy keeps a place, with tracheal models and nasal epithelial preparations standing beside the deeper lung work.呼吸道解剖学仍占一席，气管模型与鼻上皮制备同深部肺组织研究并列。
• Pulmonary vascular disease, including hypoxic pulmonary hypertension and endothelial barrier control, falls inside the same experimental frame.肺血管疾病同样在收稿范围之内，低氧性肺动脉高压与内皮屏障调控都属于这一范畴。

History

• The first volume appeared in March 1980 under the Elsevier/North-Holland imprint in New York, and the National Library of Medicine indexed it from volume 1, number 1.首卷于 1980 年 3 月由纽约的 Elsevier/North-Holland 推出，美国国家医学图书馆自第 1 卷第 1 期起收录。
• The original scope was experimental rather than clinical, a division of labour that still separates the title from respiratory medicine journals.创办之初的定位偏重实验研究，与呼吸内科期刊的分工至今清楚。
• Ownership later passed to Informa Healthcare, whose London office appears on the current National Library of Medicine record as the place of publication.出版权后来转入 Informa Healthcare，现行国家医学图书馆记录把这处伦敦出版地记作出版方所在地。
• Taylor & Francis now produces the title from London, and the entire back file sits on its digital platform under one DOI prefix.现由 Taylor & Francis 在伦敦出版，历年全文都放在其数字平台上，统一使用 10.1080 的 DOI 前缀。
• Eight numbers a year became the standard pattern from the late 1990s, and that cadence is still the one recorded in the National Library of Medicine file.1990 年代后期起每年 8 期成为标准刊期，国家医学图书馆的档案至今仍沿用这一表述。
• Two volumes a year filled the early 1980s, when volumes 3 to 13 covered 1982 to 1987, and one annual volume has been the rule since volume 14 in 1988.1980 年代前期每年出两卷，第 3 卷至第 13 卷覆盖 1982 年到 1987 年，1988 年的第 14 卷起改为每年一卷。
• Combined numbers such as 1-2 and 3-4 were used to fit eight or ten numbers into twelve months, and the last of those pairs closed volume 48 in 2022.为把 8 期或 10 期排进 12 个月，年初常用 1-2、3-4 这类合期编号，最后一对合期编号出现在 2022 年的第 48 卷。
• That pattern stopped in 2023, when volume 49 carried a single issue and accepted articles were posted online without waiting for an issue to close.这一形制在 2023 年终止，第 49 卷只编一个期号，录用的论文不必等到期号截稿即可上线。
• Crossref records for volumes 50, 51 and 52 repeat the arrangement, so each annual volume now works as a rolling collection opened at the start of the year.Crossref 中第 50 卷至第 52 卷沿用同一安排，如今每卷相当于年初开启的滚动文集。
• Full open access arrived at the same moment, and the Directory of Open Access Journals dates the journal's open access status from 2023.完全开放获取与之一同到来，《开放获取期刊目录》（DOAJ）把 2023 年记作其开放获取起点。
• Articles now carry Creative Commons licences, with CC BY and CC BY-NC both offered, and an article publishing charge of USD 2990 applies to accepted work.论文现以知识共享许可发布，CC BY 与 CC BY-NC 两种条款并行，录用稿件需付 2990 美元文章处理费。
• Impact factors sat above 2.4 in 2021 and 2022, dropped to 1.5 in 2023, then moved to 1.8 and 1.9 in the two following releases.影响因子在 2021 年与 2022 年高于 2.4，2023 年降到 1.5，随后两个年度榜分别为 1.8 与 1.9。
• Output stays deliberately small at roughly 15 papers a year, and a cited half-life of 11.1 years shows that the older volumes are still read.年发文量刻意保持在 15 篇上下，11.1 年的被引半衰期说明旧卷仍在被阅读。

Editors

• Every manuscript enters through ScholarOne Manuscripts, the submission system Taylor & Francis runs for the title, and the editorial office screens it for fit before external review.所有稿件都经由 ScholarOne Manuscripts 进入，这是 Taylor & Francis 为该刊运行的投稿系统，编辑部先做范围筛查再送外审。
• Editorial responsibility rests with an editor-in-chief, supported by associate editors and an international advisory board whose expertise spans pulmonary cell biology and developmental biology as well as toxicology and pathology.编辑责任由主编承担，副编辑与国际顾问委员会的专长覆盖肺细胞生物学与发育生物学，也覆盖毒理学与病理学。
• Referees are asked to weigh mechanistic insight and experimental design together, so a study with a modest sample can still go to full review when the preparation is clean.审稿人须同时衡量机制洞察与实验设计，样本量不大但制备干净的论文仍可能进入完整评审。
• Reviews are commissioned rather than volunteered, and proceedings of specialised symposia are published when a meeting addresses a topic the board considers timely.综述以约稿为主，一般不受理自由投稿，专业研讨会的论文集在编委会认为议题合宜时刊出。
• Methodological reports count as a standing category, and a new experimental mode becomes publishable when it opens questions that existing preparations cannot reach.方法学报告属于固定栏目，新实验模式若能触及既有制备无法回答的问题，即被视为可发表。
• Correction and retraction notices appear in the same volume as the papers they address, and volume 52 in 2026 carries both kinds beside ordinary research reports.更正与撤稿声明与其针对的论文编在同一卷内，2026 年第 52 卷就与研究论文并列刊出这两类声明。
• Because the journal is open access, the editors no longer manage subscription embargoes, and readers reach every article on the day it is posted.由于全刊开放获取，编辑部不再处理订阅封禁，读者在论文上线当日即可读到全文。
• Papers often straddle anatomy, toxicology and pathology, so the board assigns referees from more than one of those fields to a single submission.稿件常在解剖学、毒理学与病理学之间跨界，编委会为同一篇论文指派来自不止一个领域的审稿人。
• DOI registration is handled at proof stage, and reports of original measurement are expected to carry a data availability statement.DOI 在校样阶段注册，报告原始测量数据的论文须附数据可得性声明。
• Questions about fit can be put to the editorial office before a manuscript is drafted, and no formal pre-submission enquiry is required.选题是否合宜可先问编辑部，投稿前无需办理正式预审申请。